Skip to main content
Skip to main content
Normal View Dyslexic View

Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open-label randomised controlled trial.

Liu Q, Li M, Gao Y, Jiang T, Han B, Zhao G et al.
BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
Lancet Gastrohepatol 2024; 9: 428-437.
Some 161 patients were included in the study. Postoperative hospital stay was shorter after robotic surgery (median 11 vs 35 days, P=0.029). Ninety-day readmission rates were similar. There was one in-hospital death in each group.
Comment: This is a common finding after robotic surgery.

Related articles


Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial.

Bang JY, Lakhtakia S, Thakkar S, Buxbaum JL, Waxman I, Sutton B et al, on behalf of the United States Pancreatic Disease Study Group.

16 August 2024

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen J-H, Biorserud C, Bjornsson B et al, for the Nordic Pancreatic Cancer Trial-1 study group.

30 August 2024
Copied!